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1 Introduction
Genetic engineering (GE) and food processing methods are 
both being used to introduce specific beneficial proteins 
into foods and consumer products. Regulatory bodies in 
various countries differ in their requirements for evaluating 
the safety or potential risks of products that include these 
newly introduced proteins. The US, EU, and many other 
countries have now implemented requirements for eval-
uating the potential allergenicity of such products [1]. The 
primary focus, either elaborated or implied, is on prevent-
ing the transfer of a known allergen, or a protein sufficiently 
similar to a known allergen that it may trigger allergic cross-
reactions. Specific methods are used to reduce the possi-
bility of transferring an allergen or cross-reactive protein. 
One of the most informative tests is the use of computer 
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Abstract
A bioinformatics comparison of proteins introduced into food crops through genetic engineering provides a mech-
anism to identify those proteins that may present an increased risk of allergic reactions for individuals with existing 
allergies. The goal is to identify proteins that are known to be allergens or are so similar to an allergen that they 
may induce allergic cross-reactions. Three comparative approaches have traditionally been used, or considered for 
safety evaluations. One identifies any short (6–8) amino acid segment of the protein that exactly matches a known 
allergen sequence. The second is an overall primary sequence comparison using Basic Local Alignment Search 
Tool (BLAST) or FASTA to find matches of greater than 35% identity over 80 amino acids. The third is based on 3-D 
prediction programs to identify 3-D similarities that might predict potential cross-reactivity. The utility of each of 
these approaches was debated in the bioinformatics workshop. The consensus agreement from the expert work-
shop participants was that the short-segment match (e.g., 6–8 amino acids) provides an unacceptably high rate of 
false positive matches and an uncertain rate of true positive matches, and was not particularly useful for an aller-
genicity evaluation performed in the context of comprehensive safety evaluation. There was no consensus regard-
ing the most appropriate bioinformatics method, an acceptable scoring criteria for triggering closer examination 
subsequent to a positive match, or an acceptable scoring mechanism for ranking the utility of the various 3-D ap-
proaches that were discussed during the workshop. However, the general consensus was that the most practical 
approach at this time is to evaluate primary sequence identities to known allergens using either FASTA or BLAST. 
While there was good agreement that identities of greater than 35% over 80 or more amino acids (recommended 
by Codex in 2003) is quite conservative, the conclusion was that additional data or studies would be needed to 
justify changing this criterion as there is some evidence that some individuals sensitized to proteins in evolution-
arily conserved protein families may experience cross-reactions to proteins sharing approximately 40% identity. 
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programs to compare the amino acid sequence of the in-
troduced protein with those of known allergens. Any sig-
nificant resulting matches to a known allergen are used to 
identify a group of potentially at-risk individuals who could 
be tested to evaluate potential clinical risks by serum test-
ing, skin prick testing, or even food challenge. The use of 
an effective system of comparison is important for the suc-
cess of the allergenicity assessment. 
The ideal situation for the allergenicity prediction would 
be to determine whether all biologically important IgE-bind-
ing epitopes were known for all of the major allergens, and 
if computer programs could predict biologically important 
similarities between a new protein and the epitopes of an 
allergen. Unfortunately, very few epitopes have been thor-
oughly mapped for even a few allergens using sera from rep-
resentative allergic populations. Furthermore, while IgE epi-
topes may consist of short-sequential amino acid segments, 
in some cases they are formed by 3-D structures produced 
by the arrangement amino acids that are spatially close due 
to protein folding, and are therefore called discontinuous 
epitopes [2]. Even for some of the most highly studied aller-
gens, close evaluation of the sequences and 3-D structures 
have demonstrated variability between epitopes recognized 
by individuals or between apparent cross-reactive structures 
that are not perfectly conserved or predictable [3, 4]. What 
we do know about many important allergens and even minor 
allergens is the primary (amino acid) sequence of the protein. 
Therefore, the evaluation of protein sequence and structure 
have focused on the use of general local sequence alignment 
algorithms such as FASTA or Basic Local Alignment Search 
Tool (BLASTP) that are frequently used in academic research 
to efficiently identify sequences from related species that are 
likely to be homologous. Empirical results demonstrate that 
proteins that are closely matched in sequence have similar 
structure and the most highly similar protein matches found 
with these programs often correspond to antibody cross-re-
activity and clinical reactivity [5]. 
On the basis of scientific data available in the early 1990s, 
the first widely published comprehensive recommendation 
for evaluating the potential allergenicity of genetically en-
gineered crops suggested performing a local alignment by 
FASTA or BLASTP to identify probable homologs and then 
identify any exact matches of eight contiguous amino ac-
ids shared between the query sequence (GE protein) and 
any allergen [6]. Scoring parameters (gap penalties, mis-
match penalties, etc.) of both FASTA and BLAST programs 
can be modified so that results can differ markedly. While 
there are generally accepted default criteria used by either 
program to identify probable homologs, those criteria were 
not specified by Metcalfe et al. [6]. Furthermore, there has 
not been a generally recognized level of identity between 
two proteins that is considered “significant” in regard to 
the potential for cross-reactivity. As explained in the origi-
nal publication, the criterion of an eight amino acid match 
was meant to identify potentially shared IgE or T-cell epit-
opes [6]. However, questions have been raised by many au-
thors about the possibility of missing important matches 
using this criterion [7, 8]. The Food and Agriculture Orga-
nization/World Health Organization (FAO/WHO) 2001 sci-
entific panel recommended a dual test, one looking for any 
match of six contiguous amino acids, the second looking for 
identity matches above 35% over any 80 amino acid seg-
ment of the query protein compared to any known aller-
gen. The predictive value of an eight amino acid match, or 
even smaller matching segments such as six, however, had 
not been tested in published studies until around 2002. 
The FAO/WHO panel report stimulated a number of efforts 
as reported in three studies that demonstrated that more 
appropriate criteria are needed. Hileman et al. [9] found 
that roughly 80% of randomly chosen protein sequences of 
maize match an allergen if a six amino acid match is used, 
while comparisons for eight amino acid matches or those 
with >35% identity over 80 amino acids were more accu-
rate in identifying proteins with overall FASTA alignments 
that would indicate an increased potential for shared se-
quential and conformational epitopes. Kleter and Peijnen-
burg [8] found also that six amino acid matches also identify 
matches unlikely to cause cross-reactions, and they inves-
tigated using a subsequent evaluation for antigenicity pre-
diction for any matched proteins. 
There have also been suggestions that structural com-
parisons or motif recognition patterns would provide better 
predictions for evaluating the potential allergenicity of novel 
proteins [10, 11]. But to date, these methods have generally 
not been used to evaluate a wide range of proteins in the 
context of the allergenicity assessment. 
As the sequence comparison, or bioinformatics, is a very 
important part of the safety assessment process for geneti-
cally engineered crops, and significant questions have been 
raised about the best methods to perform such tests, the In-
ternational Life Sciences Institute–Health and Environmental 
Sciences Institute sponsored a scientific workshop in Mal-
lorca, Spain in February 2005 to address these questions. Par-
ticipating scientists included a broad spectrum of experts in 
bioinformatics, food safety, and allergy/allergenicity. 
This chapter will provide a brief description of bioinfor-
matics methods that have been used, or proposed for reg-
ulatory studies evaluating proteins from genetically engi-
neered crops that were discussed at the meeting. Key points 
of the discussion will be reviewed, and the points of con-
sensus or majority opinions voiced by the experts will be 
presented. 
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2 Allergen databases 
Allergen specific sequence databases [12] are very useful 
for improving the efficiency of the computerized sequence 
comparisons to identify potentially cross-reactive allergens, 
in contrast to searches using a more generalized sequence 
database such as NCBI or Swiss-Prot. A general database 
screen would require significantly more manual data analysis 
of identified matches in order to evaluate the allergenicity of 
the matched sequences. In 1996, public allergen databases 
were not available on the internet. Researchers could com-
pile their own list from GenBank or Swiss-Prot by searching 
protein or cDNA sequences with query terms such as “aller-
gen.” Now several databases of allergens — e.g., Allergenon-
line: http://allergenonline.com — are available on the inter-
net and can be queried with the amino acid sequence of any 
protein. Additionally, 3-D or structural data are available for 
a few of the most studied allergens. The focus of this paper 
is on the methods that can be used to compare a sequence 
to the database to evaluate the similarity of any protein to 
known or putative allergens. 
Two cautions are in order regarding ”allergens” in any da-
tabase. First, even the most carefully curated database will 
have a number of proteins included for which there is little 
objective evidence for allergenicity, and conversely, all will 
miss a few allergens. Second, the range of potencies, or in-
cidence of allergy associated with various proven allergens 
is wide, as is the potential reactivity if the protein is pre-
sented in food, or via the airway. These factors should be 
kept in mind when considering the potential risk of allergy 
from an introduced protein having a sequence that matches 
any allergen. 
3 Short contiguous amino acid matches 
The practice of searching for identical short amino acid 
matches between the introduced GE protein and sequences 
from known allergens had not been evaluated in terms of 
efficiency until recently [9, 10]. However, short peptide se-
quence matches have been used to evaluate most, if not all, 
of the proteins introduced into commercially available GE 
crops that have been reviewed by US, Japan and EU regula-
tors. Summary safety data for a number of GE products are 
available online: http://usbiotechreg.nbii.gov/database_ pub.
asp ; http://www.agbios.com/dbase.php . The original recom-
mendation [6] suggested first aligning the query protein (in-
troduced GE protein) with any known allergen be performed 
using FASTA or BLAST and the resulting alignments of pre-
sumably homologous sequences be evaluated for any iden-
tical eight amino acid match. Such a match was thought to 
indicate that the GE protein might cause cross-reactions in 
those allergic to the matched allergen as proteins having an 
overall alignment which suggests overall structural similarity 
and evolutionary divergence, which also has significant short 
sequence matches, may have a higher probability of sharing 
IgE epitopes. However, in practice, these searches have been 
performed using simple algorithms that were developed to 
find identical strings, or words, much like the search func-
tion of a word processing program [9]. Each individual possi-
ble contiguous amino acid sequence segment of the protein 
was used to search a selected allergen database for an exact 
match. The first search cycle would compare amino acids one 
to eight of the query to the database, the second cycle would 
query amino acids two to nine. The process would continue 
until the final eight amino acid segment is tested. Currently, 
there are at least two websites — Allermatch: http://aller-
match.org and the Structural Database of Allergenic Proteins, 
SDAP: http://fermi.utmb.edu/SDAP/ — that provide short-
segment (6 or 8 amino acids) matching algorithms. However, 
since these procedures do not first screen for potential ho-
mology, the results may be significantly different than antici-
pated by the original authors [6]. When direct string matches 
have been performed, it is clear from the high number of 
matches using common protein sequences that this method 
greatly overestimates probable allergenic matches [9]. The 
data demonstrate that the high false positive rate observed 
with six or seven amino acid matches is unacceptable and 
that the eight amino acid matches may be irrelevant. There 
are no clear data to demonstrate that this approach adds 
value over a properly performed local sequence alignment. 
4 Local alignments with FASTA or BLASTP 
FASTA [13] and BLAST [14] are computer algorithms that 
were written to provide efficient computer comparisons of 
nucleic acid or protein sequences derived from distantly re-
lated organisms. The algorithms scan each sequence in a 
database using the query sequence to identify short “seed” 
matches. If a minimal match is found, the sequence match 
is optimized to provide a best overall match for that se-
quence. As the entire database is scanned, a list is formed 
with the best matches at the top. Available scoring matrices 
that may be selected for use by the algorithm (BLOSUM 50, 
PAM 62, PAM 250, etc.) were developed with biases toward 
more (or less) conservation of structure based on struc-
turally dominant amino acids (e.g., proline, tyrosine, phe-
nylalanine) and frequencies of occurrence. Additional scor-
ing factors such as gap extension penalties (corrections for 
the insertion of an artificial gap in a sequence, to optimize 
the alignment) will alter the alignment and scores. The de-
fault settings for FASTA run on Allergenonline are BLOSUM 
50, with ktup (seed word size) of 2, gap penalty of –10, and 
gap extension penalty of –2. The resulting Z score is con-
verted into an E score that includes a correction for data-
base size and complexity. The smaller the E score the more 
similar two sequences are, and the greater the likelihood 
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they share overall structure and evolutionary heritage. In 
general, an E score value less than 0.02 indicates proba-
ble homology [15]. However, based on experience, E scores 
between 10–2 and 10–7 are relatively common between pro-
tein sequences that are evolutionarily related, but do not 
share histories of allergic cross-reactivity [9]. Since E scores 
will vary with the size of the database, and scoring matri-
ces (e.g., vicilin of walnut, GI 6580762 matches lentil aller-
gen Len c 1, GI 29539109 with an E score of 4.3 × 10–11 us-
ing FASTA with Allergenonline version 5.0, but the E score 
using BLAST with NCBI results in an E score of 9 × 10–82), 
while percentage identities are constant (39% identity over 
410 amino acid alignment for the same alignment of walnut 
and lentil proteins), it is reasonable to simply evaluate the 
E score for any match to decide whether the query protein 
sequence represents a close homologue of any allergen. 
What value of shared identity might represent a realis-
tic risk of cross-reactivity? Pearson [15], who developed the 
FASTA algorithm, observed that proteins that are apparently 
quite distantly related through evolution may share as little 
as 20–25% identity over the majority of the length of the en-
coded polypeptides and still be considered homologs. These 
proteins will usually share common structural folds and ei-
ther similar or related functions. However, Pearson [15] also 
noted that two quite distinct proteins that do not share over-
all structure or function may by chance share 50% identity 
over a segment of 20–40 amino acids. 
Aalberse [16] observed that it is rare to find true clinical 
cross-reactivity in a single patient if proteins share less than 
50% identity over their full-lengths, while proteins shar-
ing greater than 70% identity are commonly cross-reac-
tive. At the same time, the FAO/WHO expert panel recom-
mended that an identity greater than 35% over 80 or more 
amino acids should be used as a guideline to suggest pos-
sible cross-reactivity (Food and Agriculture Organization of 
the United Nations. FAO Corporate Document Repository. 
http://www.fao.org/documents/show_cdr.asp?url_file=/do-
crep/007/y0820e/y0820e00.htm ). Some very elegant studies 
have been performed that evaluate the relationship between 
clinical reactivity, in vitro binding, and histamine release of 
homologous allergens that span a wide range of sequence 
identity [5]. Those studies have shown marked reduction in 
IgE binding of 100–1000-fold for proteins sharing only ~40% 
identity. However, the examples may overestimate true cross-
reactivity because individuals are exposed to related aller-
gens and may be sensitized to one or more of the related 
homologs [17, 18]. Few other detailed studies have been per-
formed to evaluate the relationship between cross-reactiv-
ity and sequence or structural similarity with a quantitative 
measurement of binding efficacy. 
While some may argue in favor of adjusting (or not) the 
criteria of similarity matches with 35% identity over 80 amino 
acids, it is important to recognize that a match of greater 
than 50% to 70% identity over the full-length of two proteins 
is much more likely to indicate potential in vitro cross-reac-
tivity and/or clinical relevance. Although the direct proof of 
clinical cross-reactivity is nearly impossible to obtain, there 
are many studies that demonstrate the positive correlation 
between percent identity and likelihood of in vitro IgE bind-
ing and clinical reactivity. For example, Beyer et al. [19] found 
that while 12 of 14 hazelnut allergic individuals had serum 
IgE that bound to the 11S hazelnut globulin, only about one-
half experienced any clinical reactivity to the relatively unre-
lated peanut, walnut, brazil nut, cashew nut, or almond, and 
only one of those experienced reactions to more than two. 
This lack of clinical reactivity occurs despite the fact that the 
11S globulins that have been sequenced from that group 
(hazelnut, peanut, brazil nut, cashew) share between 45 and 
55% identity. Since the 11S albumins are major seed storage 
proteins, they would all be expected to share clinical symp-
toms if 45–55% identity was likely to indicate cross-reactiv-
ity. Sanchez-Monge et al. [20] found that 18 of 18 individu-
als with allergies to garden peas are also allergic to lentils. 
They identified two related pea proteins, vicilin and convi-
cilin, and fragments thereof, which appear responsible for es-
sentially all IgE reactivity in pea extract. Pea and lentil vicilins 
are ~90% identical, the two convicilins are over 70% identi-
cal and within each species, vicilin and convicilin share ap-
proximately 60% identity. 
Based on the current evidence, as well as the general ob-
servations of Aalberse [16], matches of greater than 50% 
identity by FASTA or BLAST should be evaluated very closely 
to determine whether a protein of interest may lead to cross-
reactions in individuals with existing allergies, while a match 
of less than 35–40% identity is likely to represent a much 
lower probability of cross-reactivity. Further scientific evalu-
ation of this issue will likely require specific in vitro IgE-bind-
ing studies using well-characterized sera from individuals al-
lergic to the matched allergen. The data suggests that 35% 
identity over 80 amino acids represents a very conservative 
limit for triggering further examination. In fact, this limit may 
be much lower than necessary to still protect most allergic 
individuals from the introduction of a cross-reactive protein. 
However, additional data from well-controlled studies would 
likely be required to justify raising the limit above 35% iden-
tity over 80 amino acids. 
5 Structural comparisons
 As the 3-D structure of more allergens have been either di-
rectly (X-ray crystallography or NMR) or indirectly (computer 
prediction) analyzed and compared, it is clear that many im-
portant allergens can be grouped into a small number of 
structural families [21]. This implies that the structural folds 
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of proteins within the family are similar. IgE binding to many 
allergens is conformational, meaning the epitope may be 
comprised of amino acids that are not adjacent in primary se-
quence. Structurally similar proteins are likely to share confor-
mational epitopes. Since primary structure (sequence) is an 
essential determinant for secondary structure, and secondary 
structure can alter the fine-positioning of the side-groups of 
amino acids in nonlinear epitopes, the ability of a given IgE 
antibody to bind to any region on a protein may be altered 
by the surrounding protein structure. Therefore, one could 
argue that the most appropriate way to evaluate potential 
cross-reactivity would include a comparison of 3-D structures. 
There are various programs and approaches that could be 
used to evaluate the 3-D structure of a protein, given the pri-
mary structure [10, 11, 21]. The size, hydrophobicity, polarity, 
and charge of the side-groups of each amino acid contrib-
utes to the 3-D structure. Adjacent and even relatively dis-
tant amino acids in the primary sequence will interact to in-
fluence the final protein shape. One can imagine that various 
factors and methods are used by different programs to pre-
dict overall and fine-structures of proteins, but in all cases 
the primary amino acid sequence plays an important role in 
establishing the structure. The local environment (solvent, 
pH, salt) can alter the overall shape. Some structural predic-
tion programs evaluate similarities in the overall sequences 
of proteins for specific secondary structures (e.g., likely disul-
fide bonds, alpha helices, turns) that are likely to dominate 
secondary shape and may represent an antibody epitope. 
Others focus on segments of the full-sequence, predicting 
local structures independent of the overall structure or they 
predict the overall structure and plot surface exposure [22]. 
For selected cross-reactive pairs of allergenic proteins, one 
or more of these structural prediction algorithms is likely to 
be highly predictive for estimating potential cross-reactiv-
ity. However, there do not appear to be any uniform mea-
surements of similarity that have been identified to predict 
probable cross-reactivity over a widely divergent set of pro-
teins. No one has published a measurement analogous to a 
percent identity (over the full-length, or even specified seg-
ment), that is quantifiable and tested on a diverse set of pro-
teins that are known to be cross-reactive or not cross-reac-
tive. In the future, it may be possible to develop a unified 
3–D prediction tool and criteria that would be useful for pre-
dicting potential cross-reactivity; however, further evaluation 
and additional data are needed to determine the feasibility 
of such an approach. 
6 Consensus and summary 
The participants at the bioinformatics workshop in Mallorca 
represented a wide range of scientific expertise in bioinfor-
matics, structural biochemistry, allergy, immunology, food 
science, and food safety regulations. A number of partici-
pants had previously been involved in assessing the poten-
tial allergenicity of GE crops either as a reviewer, a producer, a 
regulator, or an expert advisor to FAO/WHO or some country. 
Discussions happened throughout the workshop about the 
predictive power of various sequence and structural compar-
ison methods. New data were presented relative to the high 
incidence of randomly selected short amino acid sequences 
[23]. Therefore, a formal question was posed to all regard-
ing whether there is a useful predictive value in continuing 
to perform a short, six, seven, or eight amino acid sequence 
match. There was agreement that searches for short matches 
are not predictive and should not be used to evaluate the po-
tential allergenicity of proteins. 
There was apparent agreement that structural compari-
sons may be very useful for evaluating the cross-reactivity 
of two proteins, and predicting changes that might alter an-
tibody binding. However, much of these data were appar-
ently obtained from allergens for which some of the IgE epi-
topes have already been mapped. It was not clear, however, 
whether these methods would be predictive for proteins that 
are not highly similar in overall sequence identity. There was 
a vigorous debate as to which approach would be most pre-
dictive or whether any have the ability to predict potential 
cross-reactivity for proteins that are not closely related to a 
known allergen. There was also a lack of clarity about how 
structural similarities might be scored to provide guidance 
for the safety assessment. 
There was agreement among workshop participants that 
FASTA or BLAST algorithms comparing a query sequence to 
those of known allergens is an efficient way to identify pro-
teins that should be studied further for potential cross-reac-
tivity. There was sufficient debate to conclude that there is 
currently not enough data to change (i.e., increase) the rec-
ommended guideline (i.e., greater than 35% identity over any 
segment of 80 or more amino acids to any allergen requires 
additional testing with human serum (Food and Agriculture 
Organization of the United Nations, FAO Corporate Docu-
ment Repository, http://www.fao.org/documents/show_cdr.
asp?url_file=/docrep/007/y0820e/y0820e00.htm ; and Codex 
Alimentarius Commission, 2003, Food and Agriculture Or-
ganization of the United Nations, FAO Corporate Document 
Repository, http://www.fao.org/documents ). While a num-
ber of scientists pointed out examples where proteins with 
50% identity had not been shown to cause in vitro or in vivo 
cross-reactions, there were a few examples where proteins 
of approximately 40% identity shared some degree of in vi-
tro cross-reactivity that correlated with clinical reactions to 
the sources of those allergens. However, it was also argued 
that in at least some cases, the individuals might have been 
sensitized to other similar proteins, skewing the data. While 
a few individuals expressed some concern that there may be 
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an instance when a FASTA or BLAST search looking for >35% 
identity over 80 amino acids might miss a few cross-reactive 
matches, the general opinion seemed to be that this criteria 
is quite conservative and should continue to be used in the 
allergenicity assessment of GE proteins. 
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